N8A-16670-32770
2 vaccinations
6 coded responses
14 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 917 / CA
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Registered in v-safe
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Swollen and tender lymph nodes in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Oedema peripheral, Tenderness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Swollen, tender right axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Joint range of motion decreased, Oedema peripheral, Tenderness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Swollen, tender right axilla with limited ROM due to swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activitiesFree text: Swollen, tender right axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Peripheral swelling — Feeling: GoodFree text: Swollen right axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
-
2021-07-10
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2022-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
4 call center cases
4 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen and tender lymph nodes in axilla
Systemic reaction (other): Swollen, tender right axilla
Systemic reaction (other): Swollen, tender right axilla with limited ROM due to swelling
Systemic reaction (other): Swollen, tender right axilla
Systemic reaction (other): Swollen right axilla
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Axillary pain | ○ | ○ | ○ |
| SRO | Joint range of motion decreased | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Peripheral swelling | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release